Argenx
ARGX
#534
Rank
A$61.00 B
Marketcap
$997.74
Share price
-0.35%
Change (1 day)
91.50%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of June 2024 : A$54.31 Million

According to Argenx 's latest financial reports the company's total debt is A$54.31 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2022-12-31A$18.26 M15.47%
2021-12-31A$15.81 M2.37%
2020-12-31A$15.44 M31.91%
2019-12-31A$11.71 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31A$2.84 M2.55%
2011-12-31A$2.77 M